FOP Now Has Three Approved Drugs for About 300 US Patients, Two of Them in 37 Days
Three drugs now divide an ultra-rare disease by mechanism, route and age, and the newest competes on convenience and safety.
Three drugs now divide an ultra-rare disease by mechanism, route and age, and the newest competes on convenience and safety.
The DOJ has finalized a $38.5 million settlement with B. Braun’s Aesculap unit over allegations involving an early-failing knee implant that triggered false claims to Medicare and Medicaid.
Sweden expands reimbursement decisions driving biotech access and patient impact.
J&J invests $100M in AI in surgery funding to drive smarter surgical solutions.
Stryker FDA-cleared InCompass Ankle; protein degrader partnerships drive innovation.
Medacta highlights cutting-edge orthopedic innovations at ISAKOS 2024.
A validated capacity assessment tool designed to strengthen orthopedic surgery capabilities in low- and middle-income countries (LMICs) has demonstrated excellent reliability and practical utility in pilot testing, addressing a critical healthcare disparity that affects millions globally. The Capacity Assessment Tool for Orthopedic Surgery (CAT-os) provides systematic evaluation frameworks for surgical outreach programs targeting regions where … Read more